MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

Core Viewpoint - MacroGenics, Inc. is actively participating in the 8th Annual Evercore Healthcare Conference, highlighting its focus on innovative antibody-based therapeutics for cancer treatment [1]. Company Overview - MacroGenics is a biopharmaceutical company dedicated to developing monoclonal antibody-based therapeutics specifically for cancer treatment [3]. - The company utilizes proprietary next-generation antibody-based technology platforms to generate its pipeline of product candidates, which have broad therapeutic applications [3]. - MacroGenics has established several strategic collaborations with global pharmaceutical and biotechnology companies, leveraging its technology platforms and protein engineering expertise [3].